Replies to post #245933 on Avid Bioservices Inc (CDMO)

[Protector]

RV, just stop that. AZN pays 50% of the clinical trials. If that is no money deal for you because they pay it in kinds (Durvalumab) then fine but for most people receiving a house or receiving the cash to buy that same house is exactly the same.

Yes, they pay MSK, but MSK is a party that doesn't let just anyone pay them for anything. They can pick and they picked Bavituximab in the worlds #1 Lab for IO, Wolchok's Lab.

But even then, my post was MUCH MORE in depth making the point then what you singled out of it.

There is NO comparison between PPHM NOW, the INFO NOW, the CASH situation NOW, the evolution of Bavi NOW, the collaborations and partnerships NOW with WHATEVER in the past you may want to compare with.

[Couch]

AZN hands over their drug for free and calls it a partnership publicly, then moves forward with a second Phase 2 trial and we need to define the definition of a partnership. That's a good one. LOL